Mineralys Therapeutics – A targeted approach for the control of hypertension

Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.

We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone.